Taro Hirai
5PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Oct 24, 2025
SGLT2 Inhibitors Modify Fibrosis-4 Index and Mitigate the Development of DKD: Role of Background Antidiabetic Drugs.Keisuke Takano, Koichi Hayashi, Koichi Kitamura
|Jan 11, 2022
Effects of SGLT2 Inhibitors on Atherosclerosis: Lessons from Cardiovascular Clinical Outcomes in Type 2 Diabetic Patients and Basic Researches.Jing Xu, Taro Hirai, Daisuke Koya
|Jan 08, 2021
Sodium-glucose cotransporter 2 inhibitors in type 2 diabetes patients with renal function impairment slow the annual renal function decline, in a real clinical practice.Taro Hirai, Munehiro Kitada, Itaru Monno
|Feb 06, 2020
Case report of superior mesenteric artery syndrome that developed in a lean type 2 diabetes patient and was associated with rapid body weight loss after sodium-glucose cotransporter 2 inhibitor administration.Taro Hirai, Munehiro Kitada, Yoshihiro Hayashi
Pageof 1
